Quantcast

Latest liver disease Stories

2014-07-22 08:32:59

TEL AVIV, Israel, July 22, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones, announced today that the U.S. Food and Drug Administration, or the FDA, cleared Galmed's Investigational New Drug, or IND, application. Such clearance will permit Galmed to conduct clinical trials of...

2014-07-15 23:10:56

The Fatty Liver Bible & Ezra Protocol review that was just updated by Vkool.com reveals Debra Elkin’s home treatment system that promises efficiency in treating fatty liver and obesity. Seattle, Wa (PRWEB) July 15, 2014 According to the Fatty Liver Bible & Ezra Protocol review recently updated by Vkool.com, this is a helpful guide that provides readers with a wide range of tips and advice on how to resolve fatty liver and obesity. This book consists of 8 chapters including:...

2014-07-08 12:28:47

TEL AVIV, Israel, July 8, 2014 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq:GLMD) ("Galmed") today announced the recent publication of the results of its Phase IIa clinical trial of aramchol in the peer-reviewed Clinical Gastroenterology and Hepatology Journal. The trial manuscript, entitled "The Fatty Acid-Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients with Nonalcoholic Fatty Liver Disease," provides the full report of the Phase IIa trial, which was...

2014-06-25 23:08:47

Transparency Market Research has published a new report titled "Global Liver Diseases Therapeutics Market: Industry Analysis, Size, Share, Trends and Forecast 2012 - 2018" to its report store. Browse the full report: http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html. Albany, New York (PRWEB) June 25, 2014 The report on “Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry...

2014-06-23 09:37:29

Monash University An international team of scientists led by Monash University researchers has shown how free radicals contribute to type 2 diabetes, obesity and fatty liver disease. Type 2 diabetes and non-alcoholic fatty liver disease are key complications of obesity as 80 per cent of patients with type 2 diabetes are obese, and 75 per cent of patients who are obese or have type 2 diabetes also have fatty liver disease. The team, led by Professor Tony Tiganis from the Department...

2014-06-23 08:29:48

SOUTH SAN FRANCISCO, Calif., June 23, 2014 /PRNewswire/ -- Tobira Therapeutics, a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today the appointment of four directors to its Board: Jeffrey H. Cooper, Craig S. Gibbs, Ph.D., Gwen A. Melincoff and Graeme J. Moyle, M.B.B.S., M.D. "I am very pleased to add to our Board of Directors a group of diverse and talented individuals who bring a wealth of experience and unique skill set...

2014-06-11 23:07:57

Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has been recruited to lead a newly established Institute of Cellular Therapeutics based at Allegheny General Hospital (AGH). Pittsburgh, PA (PRWEB) June 11, 2014 Allegheny Health Network today announced that Massimo Trucco, MD, one of the world’s foremost physician-scientists with expertise in diabetes and immunogenetics, has...

2014-06-04 15:37:59

Washington University in St. Louis Studying mice, researchers have found a way to prevent nonalcoholic fatty liver disease, the most common cause of chronic liver disease worldwide. Blocking a path that delivers dietary fructose to the liver prevented mice from developing the condition, according to investigators at Washington University School of Medicine in St. Louis. The study appears in a recent issue of The Journal of Biological Chemistry. In people, nonalcoholic fatty liver...

2014-05-19 23:13:03

Fatty Liver Cookbook created by Debra Elkin is a new program that introduces to people a fatty live diet plan and strategies on how to reverse their fatty liver disease and obesity naturally. An overview on the website Vinaf.com shows if the program is good for people to use. New York, NY (PRWEB) May 19, 2014 Fatty Liver Cookbook is a new program developed by Debra Elkin, a health consultant, who has over 19 years of experience in the health industry. The program provides people with a...

2014-05-16 23:10:04

Chinese Secrets To Fatty Liver And Obesity Reversal created by Abe Hsieh is a new program that introduces to people a fatty live diet plan and strategies on how to reverse their fatty liver disease and obesity naturally. An overview on the website Vinaf.com shows if the program is good for people to use. (PRWEB) May 16, 2014 Chinese Secrets To Fatty Liver And Obesity Reversal is a new program developed by Abe Hsieh, a health consultant, who has over 19 years of experience in the health...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related